| Q36618716 | 20-HETE Activates the Transcription of Angiotensin-Converting Enzyme via Nuclear Factor-κB Translocation and Promoter Binding |
| Q64097766 | A Review and Hypothesized Model of the Mechanisms That Underpin the Relationship Between Inflammation and Cognition in the Elderly |
| Q34550375 | A genome-wide methylation study on essential hypertension in young African American males |
| Q80143511 | ABCB1 (P-glycoprotein) but not ABCC1 (MRP1) is downregulated in peripheral blood mononuclear cells of spontaneously hypertensive rats |
| Q93115123 | ATP release drives heightened immune responses associated with hypertension |
| Q36114299 | Activation of angiotensin II type 2 receptor suppresses TNF-α-induced ICAM-1 via NF-кB: possible role of ACE2 |
| Q34780122 | Androgen-dependent hypertension is mediated by 20-hydroxy-5,8,11,14-eicosatetraenoic acid-induced vascular dysfunction: role of inhibitor of kappaB Kinase |
| Q38613516 | Angeli's Salt, a nitroxyl anion donor, reverses endothelin-1 mediated vascular dysfunction in murine aorta |
| Q36972703 | Angiotensin II AT1 receptor blockade decreases lipopolysaccharide-induced inflammation in the rat adrenal gland |
| Q33765684 | Angiotensin receptor type 1 and endothelin receptor type A on immune cells mediate migration and the expression of IL-8 and CCL18 when stimulated by autoantibodies from systemic sclerosis patients |
| Q33773490 | Angiotensin-converting enzyme 2 (ACE2) activator diminazene aceturate ameliorates endotoxin-induced uveitis in mice |
| Q37281652 | Anti-inflammatory effects of angiotensin receptor blockers in the brain and the periphery |
| Q27016563 | Antioxidant-based therapies for angiotensin II-associated cardiovascular diseases |
| Q41903293 | Aorta from angiotensin II hypertensive mice exhibit preserved nitroxyl anion mediated relaxation responses |
| Q59100706 | Association between hypertension and periodontitis: possible mechanisms |
| Q36596072 | Association between insufficient medication of antihypertensives and the severity of acute ischemic stroke. |
| Q34265289 | Association of a butyrophilin, subfamily 2, member A1 gene polymorphism with hypertension |
| Q35234550 | Association of genetic variants with hypertension in a longitudinal population-based genetic epidemiological study |
| Q36299207 | Association of inflammatory gene polymorphisms with ischemic stroke in a Chinese Han population |
| Q47442728 | Biomarkers of inflammation and endothelial dysfunction as predictors of pulse pressure and incident hypertension in type 1 diabetes: a 20 year life-course study in an inception cohort. |
| Q50455443 | Biomechanical Strain Exacerbates Inflammation on a Progeria-on-a-Chip Model. |
| Q35778292 | Blood Mercury and Insulin Resistance in Nondiabetic Koreans (KNHANES 2008-2010). |
| Q35132428 | Brain inflammation is induced by co-morbidities and risk factors for stroke |
| Q38644425 | Bridging the Gap between Gut Microbial Dysbiosis and Cardiovascular Diseases |
| Q39688016 | Calcineurin inhibitors cyclosporine A and tacrolimus induce vascular inflammation and endothelial activation through TLR4 signaling. |
| Q33888096 | Captopril reduces cardiac inflammatory markers in spontaneously hypertensive rats by inactivation of NF-kB |
| Q37595599 | Cardiovascular effects of losartan and its relevant clinical application |
| Q33842137 | Circulating angiotensin II gains access to the hypothalamus and brain stem during hypertension via breakdown of the blood-brain barrier |
| Q42222947 | Consumption of hydrogen-rich water alleviates renal injury in spontaneous hypertensive rats |
| Q52725842 | Cyclic Strain and Hypertension Increase Osteopontin Expression in the Aorta. |
| Q35857205 | Diabetes and hypertension: is there a common metabolic pathway? |
| Q47103979 | Differential vascular cell adhesion molecule-1 expression and superoxide production in simulated microgravity rat vasculature |
| Q43116626 | Does inflammation fuel the fire in CKD? |
| Q39255865 | Does one size fit all? The role of body mass index and waist circumference in systemic inflammation in midlife by race and gender |
| Q36101886 | Downregulating p22phox ameliorates inflammatory response in Angiotensin II-induced oxidative stress by regulating MAPK and NF-κB pathways in ARPE-19 cells |
| Q37174707 | Female spontaneously hypertensive rats have greater renal anti-inflammatory T lymphocyte infiltration than males |
| Q35810721 | From Brain to Behavior: Hypertension's Modulation of Cognition and Affect |
| Q27016011 | HIV and aging: emerging research issues |
| Q38868376 | Hyperpulsatile pressure, systemic inflammation and cardiac stress are associated with cardiac wall remodeling in an African male cohort: the SABPA study |
| Q35318592 | Hypothalamic inflammation: a double-edged sword to nutritional diseases |
| Q38029918 | Impact of the AT(2) receptor agonist C21 on blood pressure and beyond |
| Q37359675 | In vivo Angiotensin II AT1 receptor blockade selectively inhibits LPS-induced innate immune response and ACTH release in rat pituitary gland |
| Q36552310 | Inhibition of the renin angiotensin system: implications for the endothelium |
| Q64268102 | Inhibitory Effects of Roseoside and Icariside E4 Isolated from a Natural Product Mixture (No-ap) on the Expression of Angiotensin II Receptor 1 and Oxidative Stress in Angiotensin II-Stimulated H9C2 Cells |
| Q58795465 | Integrated Systems Biology Approach Identifies Novel Maternal and Placental Pathways of Preeclampsia |
| Q36406495 | Interleukin 6 knockout prevents angiotensin II hypertension: role of renal vasoconstriction and janus kinase 2/signal transducer and activator of transcription 3 activation |
| Q41546343 | Interleukin-1 mediates neuroinflammatory changes associated with diet-induced atherosclerosis |
| Q34292579 | Investigating the potential role of TRPA1 in locomotion and cardiovascular control during hypertension. |
| Q36237011 | Investigation of relationship between IL-6 gene variants and hypertension in Turkish population |
| Q28388335 | Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases |
| Q24321728 | Kruppel-like factor 15 is critical for vascular inflammation |
| Q35997131 | Longitudinal genome-wide methylation study of Roux-en-Y gastric bypass patients reveals novel CpG sites associated with essential hypertension |
| Q36014454 | Low-grade inflammation, metabolic syndrome and the risk of chronic kidney disease: the 2005 Korean National Health and Nutrition Examination Survey |
| Q37590371 | Mechanisms of fibrinogen-induced microvascular dysfunction during cardiovascular disease |
| Q28069771 | Neuroinflammation at the interface of depression and cardiovascular disease: Evidence from rodent models of social stress |
| Q27013624 | Neuroinflammation in overnutrition-induced diseases |
| Q26852584 | Neuroinflammatory basis of metabolic syndrome |
| Q28395530 | Once upon a mine: the legacy of uranium on the Navajo Nation |
| Q35825406 | Panax Notoginseng flower saponins (PNFS) inhibit LPS-stimulated NO overproduction and iNOS gene overexpression via the suppression of TLR4-mediated MAPK/NF-kappa B signaling pathways in RAW264.7 macrophages |
| Q36429992 | Periodontal disease and incidence of hypertension in the health professionals follow-up study |
| Q36579387 | Periodontal disease, hypertension, and blood pressure among older adults in Puerto Rico |
| Q41087339 | Peripheral Inflammation, Apolipoprotein E4, and Amyloid-β Interact to Induce Cognitive and Cerebrovascular Dysfunction |
| Q91854944 | Pharmacological myeloperoxidase (MPO) inhibition in an obese/hypertensive mouse model attenuates obesity and liver damage, but not cardiac remodeling |
| Q35114669 | Plasma prolactin level and risk of incident hypertension in postmenopausal women |
| Q28391417 | Polychlorinated biphenyls and links to cardiovascular disease |
| Q37198932 | Possible role of plasma ceruloplasmin and erythrocyte sedimentation rate in assessing compliance with occupational hygiene and safety practices in waste management workers |
| Q52641505 | Presenting a New Standard Drug Model for Turmeric and Its Prized Extract, Curcumin. |
| Q85289622 | Procalcitonin and Pentraxin-3: Current biomarkers in inflammation in white coat hypertension |
| Q54944425 | Protective effects of long-term administration of Ziziphus jujuba fruit extract on cardiovascular responses in L-NAME hypertensive rats. |
| Q57821597 | Quantification of Multifunctional Dipeptide YA from Oyster Hydrolysate for Quality Control and Efficacy Evaluation |
| Q36596821 | Reduction of C-reactive protein and the use of anti-hypertensives. |
| Q37410552 | Relationship between IL-17 serum level and ambulatory blood pressure in women with polycystic ovary syndrome |
| Q37615013 | Relationship between Metabolic Syndrome and Its Components with Psychological Distress |
| Q41549740 | Renal protective effects of N-acetyl-Ser-Asp-Lys-Pro in deoxycorticosterone acetate–salt hypertensive mice |
| Q37269647 | Renin-angiotensin system revisited |
| Q33950754 | Ribonucleic acid interference knockdown of interleukin 6 attenuates cold-induced hypertension |
| Q36495144 | Role of NADPH oxidase and iNOS in vasoconstrictor responses of vessels from hypertensive and normotensive rats. |
| Q26995130 | Role of fibrinogen in cerebrovascular dysfunction after traumatic brain injury |
| Q33702090 | Rosuvastatin attenuates the elevation in blood pressure induced by overexpression of human C-reactive protein. |
| Q55246908 | SB-216763, a GSK-3β inhibitor, protects against aldosterone-induced cardiac, and renal injury by activating autophagy. |
| Q36007378 | Secreted protein acidic and rich in cysteine deficiency ameliorates renal inflammation and fibrosis in angiotensin hypertension |
| Q64889213 | Selective inhibition of histone deacetylase 8 improves vascular hypertrophy, relaxation, and inflammation in angiotensin II hypertensive mice. |
| Q54976068 | Serum Presepsin Levels Are Not Elevated in Patients with Controlled Hypertension. |
| Q36040675 | Smooth muscle protein 22 alpha-Cre is expressed in myeloid cells in mice. |
| Q37656716 | Systemic Inflammation in Midlife: Race, Socioeconomic Status, and Perceived Discrimination. |
| Q35837781 | TAK-242, a Toll-Like Receptor 4 Antagonist, Protects against Aldosterone-Induced Cardiac and Renal Injury |
| Q53499295 | TLR4 as a possible key regulator of pathological vascular remodeling by Ang II receptor activation. |
| Q40061950 | The Temporal Relationship between Arterial Stiffening and Blood Pressure Is Modified by Methotrexate Treatment in Patients with Rheumatoid Arthritis |
| Q35038155 | The immune system and hypertension. |
| Q39538319 | The new vitamin E derivative, ETS-GS, protects against cecal ligation and puncture-induced systemic inflammation in rats |
| Q33524559 | The relation of C--reactive protein to chronic kidney disease in African Americans: the Jackson Heart Study |
| Q33579257 | The role of aldosterone in mediating the dependence of angiotensin hypertension on IL-6. |
| Q37261536 | The role of tissue Renin-Angiotensin-aldosterone system in the development of endothelial dysfunction and arterial stiffness. |
| Q33629776 | Time-cumulated blood pressure exposure and incident impairment of glucose tolerance and diabetes mellitus |
| Q42593944 | Toll-like receptor 4 contributes to vascular remodelling and endothelial dysfunction in angiotensin II-induced hypertension |
| Q37055979 | Transient receptor potential melastatin 6 and 7 channels, magnesium transport, and vascular biology: implications in hypertension |
| Q42058427 | Uncoupling the mechanisms of obesity and hypertension by targeting hypothalamic IKK-β and NF-κB. |
| Q38029531 | Using optogenetics to translate the "inflammatory dialogue" between heart and brain in the context of stress |
| Q35207893 | Vascular inflammation and endothelial dysfunction in experimental hypertension. |